These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 39111965)

  • 1. Volatile organic compounds in cancer and exhaled breath detection technology.
    Zhou X; Qi M; Tang M; Wen S; Xue Z; Wang T
    Adv Clin Chem; 2024; 122():53-114. PubMed ID: 39111965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress and challenges of developing volatile metabolites from exhaled breath as a biomarker platform.
    Chou H; Godbeer L; Allsworth M; Boyle B; Ball ML
    Metabolomics; 2024 Jul; 20(4):72. PubMed ID: 38977623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volatile organic compounds in exhaled breath: a promising approach for accurate differentiation of lung adenocarcinoma and squamous cell carcinoma.
    Li X; Shi L; Long Y; Wang C; Qian C; Li W; Tian Y; Duan Y
    J Breath Res; 2024 Aug; 18(4):. PubMed ID: 39019071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exhaled breath and urinary volatile organic compounds (VOCs) for cancer diagnoses, and microbial-related VOC metabolic pathway analysis: a systematic review and meta-analysis.
    Zhou M; Wang Q; Lu X; Zhang P; Yang R; Chen Y; Xia J; Chen D
    Int J Surg; 2024 Mar; 110(3):1755-1769. PubMed ID: 38484261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exhaled breath biopsy: a new cancer detection paradigm.
    Abderrahman B
    Future Oncol; 2019 May; 15(15):1679-1682. PubMed ID: 30977676
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of volatile organic compounds (VOCs) from exhaled breath as noninvasive methods for cancer diagnosis.
    Sun X; Shao K; Wang T
    Anal Bioanal Chem; 2016 Apr; 408(11):2759-80. PubMed ID: 26677028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influences of mixed expiratory sampling parameters on exhaled volatile organic compound concentrations.
    Thekedar B; Oeh U; Szymczak W; Hoeschen C; Paretzke HG
    J Breath Res; 2011 Mar; 5(1):016001. PubMed ID: 21383425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of recent developments in determining volatile organic compounds in exhaled breath as biomarkers for lung cancer diagnosis.
    Zhou J; Huang ZA; Kumar U; Chen DDY
    Anal Chim Acta; 2017 Dec; 996():1-9. PubMed ID: 29137702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting.
    Mangler M; Freitag C; Lanowska M; Staeck O; Schneider A; Speiser D
    Ginekol Pol; 2012 Oct; 83(10):730-6. PubMed ID: 23383557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breath volatile organic compounds (VOCs) as biomarkers for the diagnosis of pathological conditions: A review.
    Moura PC; Raposo M; Vassilenko V
    Biomed J; 2023 Aug; 46(4):100623. PubMed ID: 37336362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the importance of accurate quantification of individual volatile metabolites in exhaled breath.
    Smith D; Španěl P
    J Breath Res; 2017 Nov; 11(4):047106. PubMed ID: 28635619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breath VOC analysis and machine learning approaches for disease screening: a review.
    P H; Rangarajan M; Pandya HJ
    J Breath Res; 2023 Feb; 17(2):. PubMed ID: 36634360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis by Volatile Organic Compounds in Exhaled Breath in Exhaled Breath from Patients with Gastric and Colorectal Cancers.
    Chung J; Akter S; Han S; Shin Y; Choi TG; Kang I; Kim SS
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers.
    Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD
    J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting cancer by breath volatile organic compound analysis: a review of array-based sensors.
    Queralto N; Berliner AN; Goldsmith B; Martino R; Rhodes P; Lim SH
    J Breath Res; 2014 Jun; 8(2):027112. PubMed ID: 24862241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of volatile organic compounds in exhaled breath by gas chromatography-mass spectrometry combined with chemometric analysis.
    Dallinga JW; Smolinska A; van Schooten FJ
    Methods Mol Biol; 2014; 1198():251-63. PubMed ID: 25270934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy and Methodologic Challenges of Volatile Organic Compound-Based Exhaled Breath Tests for Cancer Diagnosis: A Systematic Review and Meta-analysis.
    Hanna GB; Boshier PR; Markar SR; Romano A
    JAMA Oncol; 2019 Jan; 5(1):e182815. PubMed ID: 30128487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Volatile signature for the early diagnosis of lung cancer.
    Gasparri R; Santonico M; Valentini C; Sedda G; Borri A; Petrella F; Maisonneuve P; Pennazza G; D'Amico A; Di Natale C; Paolesse R; Spaggiari L
    J Breath Res; 2016 Feb; 10(1):016007. PubMed ID: 26857451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exhaled volatile organic compounds analysis in clinical pediatrics: a systematic review.
    Sola Martínez RA; Pastor Hernández JM; Yanes Torrado Ó; Cánovas Díaz M; de Diego Puente T; Vinaixa Crevillent M
    Pediatr Res; 2021 May; 89(6):1352-1363. PubMed ID: 32919397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
    Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
    Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.